Record MS-N190 · Supportive care · Last literature search and appraisal: 31 October 2026
Evidence at a glance
- Evidence label: Possible short-term symptom benefit; one small trial
- Potential benefit: In a 64-person randomized trial, fatigue scores were lower with slow-stroke back massage than with routine care at three chemotherapy-cycle assessments.
- Risk: Light massage is generally low risk, but oncology-specific modification matters when skin is injured, blood counts are low, clot risk is present or bone is fragile.
- What this evidence is about: Fatigue support during chemotherapy; no cancer-control outcome was studied.
What was studied
Sixty-four women receiving breast-cancer chemotherapy were randomized 1:1. The intervention was 20 minutes—10 minutes before and 10 minutes after each infusion—during cycles two, three and four; control participants received routine care. Brief Fatigue Inventory scores favored massage at all three reported time points (reported P<0.001), and change over time in the massage group was significant (P=0.018; η²=0.14). The abstract did not provide absolute group scores, confidence intervals, analyzed denominators or a prespecified clinically meaningful threshold.
What the evidence cannot establish
Assessor blinding helps, but participant/provider blinding was impossible and routine care does not control for attention or touch. Single-center, women with breast cancer only, short follow-up. Appraisal was limited to the indexed abstract; full text was not verified. Funding, conflicts and detailed adverse events were not reported in the abstract.
Symptom improvement is not evidence of tumor shrinkage, delayed recurrence or longer survival. This record does not support replacing oncology treatment.
Practical safety context
Persistent or worsening fatigue can reflect anemia, infection, endocrine problems, sleep disruption, medication effects or cancer progression. Massage should complement—not delay—assessment. Use gentle pressure and avoid ports, infusion sites, fresh surgery, inflamed/radiated skin and areas at risk from metastases or thrombosis.
Questions for the care team
- Has a reversible medical cause of fatigue been checked?
- Can the oncology team clear massage around my infusion schedule and blood counts?
- Will fatigue be tracked with the same scale beyond the treatment day?
Sources checked
Source note: Publication dates refer to the indexed paper; links were checked on 31 October 2026. A registry entry verifies design or status, not efficacy. Unreported fields are not assumed to be absent.
Education only: This evidence summary is not personal medical advice. Decisions about symptoms, treatment interactions and complementary care belong with your oncology team.
